2020

1. First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL study

   Journal of Geriatric Oncology, Vol. 11, Núm. 8, pp. 1263-1267

2. First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial

   Clinical and Translational Oncology, Vol. 22, Núm. 4, pp. 495-502